Drugs / Brinzolamide/brimonidine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01309204 | May 2011 → Jan 2013 | ocular hypertension, open-angle glaucoma | Alcon Research | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Brinzolamide/brimonidine | “Randomized trial of brinzolamide/brimonidine versus brinzolamide plus brimonidine for open-angle glaucoma or ocular hypertension.” PMID 25430900 ↗ Nov 2014 |
| Known as | BBFC | “The aim of this study was to evaluate the safety and efficacy of fixed-combination brinzolamide 1%/brimonidine 0.2% (BBFC) versus concomitant administration of brinzolamide 1%...” PMID 25430900 ↗ Nov 2014 |
| Route | Other | “1 drop instilled in each eye” NCT01309204 ↗ |